Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis

Brittany Duchene1

  • 1Northeastern Vermont Regional Hospital, 1315 Hospital Drive, St. Johnsbury, VT, 05819, USA.

PubMed

Insights

Microscopic polyangiitis (MPA) can manifest as interstitial lung disease (ILD), mimicking idiopathic pulmonary fibrosis (IPF). Early screening for vasculitis in suspected IPF cases is crucial to prevent misdiagnosis.

Area of Science:

  • Pulmonary Medicine
  • Rheumatology
  • Immunology

Background:

  • Microscopic polyangiitis (MPA) is a form of systemic vasculitis.
  • Usual interstitial pneumonia (UIP) is the most common pulmonary manifestation of MPA, seen in 48% of patients.
  • Interstitial lung disease (ILD) can be the initial presentation of MPA in 22% of cases.

Observation:

  • A patient initially diagnosed with idiopathic pulmonary fibrosis (IPF) later presented with pulmonary infiltrates and hemoptysis.
  • Bronchoscopy revealed diffuse alveolar hemorrhage.
  • The patient was subsequently diagnosed with MPA.

Findings:

  • MPA can present with symptoms and imaging findings that overlap with IPF.
  • Diffuse alveolar hemorrhage is a key indicator that may suggest an underlying vasculitis.
  • Current diagnostic guidelines lack routine screening for vasculitis in suspected IPF cases.

Implications:

  • Misdiagnosis of vasculitis as IPF can delay appropriate treatment.
  • Implementing routine screening for vasculitis in specific IPF presentations may improve diagnostic accuracy.
  • This case highlights the importance of considering systemic vasculitis in patients with unexplained pulmonary findings.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
3
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
152
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
212
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
239